Generative AI for protein design
Company is active
Event Year: 2023
Company is active
Event Year: 2023
Diffuse Bio is dedicated to revolutionizing protein design through the application of generative artificial intelligence. The company's core mission is to develop AI-driven systems capable of engineering novel and functional proteins with exceptional precision and control. With a team possessing over seven years of experience in pioneering AI protein design, Diffuse Bio has been instrumental in achieving significant milestones, including the initial experimental validation of proteins generated by AI and the application of diffusion models for protein structure and sequence determination. Diffuse Bio aims to leverage these advancements to create groundbreaking solutions in various fields, including medicine and biotechnology.
Diffuse Bio is dedicated to revolutionizing protein design through the application of generative artificial intelligence. The company's core mission is to develop AI-driven systems capable of engineering novel and functional proteins with exceptional precision and control. With a team possessing over seven years of experience in pioneering AI protein design, Diffuse Bio has been instrumental in achieving significant milestones, including the initial experimental validation of proteins generated by AI and the application of diffusion models for protein structure and sequence determination. Diffuse Bio aims to leverage these advancements to create groundbreaking solutions in various fields, including medicine and biotechnology.
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2023
Total Raised: Unknown (Y Combinator backed)
Last Round: Winter 2023
Healthcare
Healthcare
Healthcare -> Drug Discovery and Delivery
Healthcare -> Drug Discovery and Delivery
Team size: 10
Hiring: Yes
Team size: 10
Hiring: Yes
